Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
by
Sylvester, Caroline
, Brenner, Thorsten
, Glanz, Karolina
, Manoochehri, Mehdi
, Sohn, Kai
, Kattner, Simone
, Berger, Marc Moritz
, Müller, Jan
, Vainshtein, Yevhen
in
631/337/2019
/ 692/308/53/2423
/ Acetylcholinesterase
/ Biomarkers
/ Blood
/ Cell differentiation
/ Coronaviruses
/ COVID-19
/ COVID-19 - genetics
/ Critical Illness
/ Gene expression
/ Hematopoietic stem cells
/ Humanities and Social Sciences
/ Humans
/ Intensive Care Units
/ Lectins, C-Type - genetics
/ multidisciplinary
/ Organ Dysfunction Scores
/ Patients
/ Prognosis
/ Receptors, Mitogen
/ Retrospective Studies
/ Risk Assessment
/ ROC Curve
/ Science
/ Science (multidisciplinary)
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
by
Sylvester, Caroline
, Brenner, Thorsten
, Glanz, Karolina
, Manoochehri, Mehdi
, Sohn, Kai
, Kattner, Simone
, Berger, Marc Moritz
, Müller, Jan
, Vainshtein, Yevhen
in
631/337/2019
/ 692/308/53/2423
/ Acetylcholinesterase
/ Biomarkers
/ Blood
/ Cell differentiation
/ Coronaviruses
/ COVID-19
/ COVID-19 - genetics
/ Critical Illness
/ Gene expression
/ Hematopoietic stem cells
/ Humanities and Social Sciences
/ Humans
/ Intensive Care Units
/ Lectins, C-Type - genetics
/ multidisciplinary
/ Organ Dysfunction Scores
/ Patients
/ Prognosis
/ Receptors, Mitogen
/ Retrospective Studies
/ Risk Assessment
/ ROC Curve
/ Science
/ Science (multidisciplinary)
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
by
Sylvester, Caroline
, Brenner, Thorsten
, Glanz, Karolina
, Manoochehri, Mehdi
, Sohn, Kai
, Kattner, Simone
, Berger, Marc Moritz
, Müller, Jan
, Vainshtein, Yevhen
in
631/337/2019
/ 692/308/53/2423
/ Acetylcholinesterase
/ Biomarkers
/ Blood
/ Cell differentiation
/ Coronaviruses
/ COVID-19
/ COVID-19 - genetics
/ Critical Illness
/ Gene expression
/ Hematopoietic stem cells
/ Humanities and Social Sciences
/ Humans
/ Intensive Care Units
/ Lectins, C-Type - genetics
/ multidisciplinary
/ Organ Dysfunction Scores
/ Patients
/ Prognosis
/ Receptors, Mitogen
/ Retrospective Studies
/ Risk Assessment
/ ROC Curve
/ Science
/ Science (multidisciplinary)
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
Journal Article
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
2023
Request Book From Autostore
and Choose the Collection Method
Overview
In order to identify biomarkers for earlier prediction of COVID-19 outcome, we collected blood samples from patients with fatal outcomes (non-survivors) and with positive clinical outcomes (survivors) at ICU admission and after seven days. COVID-19 survivors and non-survivors showed significantly different transcript levels for 93 genes in whole blood already at ICU admission as revealed by RNA-Seq. These differences became even more pronounced at day 7, resulting in 290 differentially expressed genes. Many identified genes play a role in the differentiation of hematopoietic cells. For validation, we designed an RT-qPCR assay for C-type lectin domain family 12 member A (
CLEC12A
) and acetylcholinesterase (
ACHE
), two transcripts that showed highest potential to discriminate between survivors and non-survivors at both time points. Using our combined RT-qPCR assay we examined 33 samples to accurately predict patient survival with an AUROC curve of 0.931 (95% CI = 0.814–1.000) already at ICU admission.
CLEC12A
and
ACHE
showed improved prediction of patient outcomes compared to standard clinical biomarkers including CRP and PCT in combination (AUROC = 0.403, 95% CI = 0.108–0.697) or SOFA score (AUROC = 0.701 95% CI = 0.451–0.951) at day 0. Therefore, analyzing
CLEC12A
and
ACHE
gene expression from blood may provide a promising approach for early risk stratification of severely ill COVID-19 patients.
This website uses cookies to ensure you get the best experience on our website.